Programming Strategies and Trial Optimization
Part of Neuromodulation for Chronic Abdominal Discomfort Syndrome: Targets, Techniques, and Outcomes
Details
- Date
- Friday, January 22, 2027
- Time
- 11:21 AM – 11:36 AM
- Session type
- Concurrent Session
- Schedule
- See this day
About
Chronic Abdominal Discomfort Syndrome (CADS) represents a newly defined clinical entity characterized by persistent abdominal pain without clear structural pathology yet associated with visceral afferent sensitization and central modulation dysfunction. Neuromodulation - targeting DRG (T11-L2), splanchnic nerves, and celiac plexus pathways -offers a promising therapeutic strategy for select phenotypes. However, standardized patient selection, programming strategies, and long-term durability data remain limited. This session provides a structured, phenotype-based approach to visceral neuromodulation.
Presenters
-
Alaa A Abd-Elsayed, MD, MPH
Medical Director
Department of Anesthesiology, University of WI School of Medicine and Public Health · Madison, Wisconsin
Dr Abd-Elsayed serves as the Medical Director of UW Health Pain Services, Division Chief of Chronic Pain Medicine, and Professor of Anesthesiology at the University of Wisconsin in Madison. He has published more than 400 peer-reviewed manuscripts, edited about 40 books, and serves on the editorial board of several journals.
-
Alaa A Abd-Elsayed, MD, MPH
Medical Director
Department of Anesthesiology, University of WI School of Medicine and Public Health · Madison, Wisconsin
Dr Abd-Elsayed serves as the Medical Director of UW Health Pain Services, Division Chief of Chronic Pain Medicine, and Professor of Anesthesiology at the University of Wisconsin in Madison. He has published more than 400 peer-reviewed manuscripts, edited about 40 books, and serves on the editorial board of several journals.